Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive factors for ovarian response with fixed-dose recombinant FSH in GnRH antagonist IVF regimen with or without oral contraceptive scheduling
2006-000481-37Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of follitropin beta in female infertility and hypofertility (2 arms), sponsored by Organon & Co. Primary endpoint: Total number of oocytes at oocyte pick-up. Started Aug 2006; status: completed.
02
Drugs
follitropin beta
03
Conditions
female infertilityhypofertility
Beyond the preview
Go deeper on 2006-000481-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000481-37.